WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006081515) DULOXETINE HYDROCHLORIDE POLYMORPHS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/081515    International Application No.:    PCT/US2006/003126
Publication Date: 03.08.2006 International Filing Date: 27.01.2006
IPC:
C07D 333/20 (2006.01), A61K 31/381 (2006.01)
Applicants: TEVA PHARMACEUTICAL INDUSTRIES LTD. [IL/IL]; 5 Basel Street, P.o. Box 3190, 49131 Petah Tiqva (IL) (AE, AG, AL, AM, AT, AU, AZ, BA, BE, BF, BG, BJ, BR, BW, BY, BZ, CA, CF, CG, CH, CI, CM, CN, CO, CR, CU, CY, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, FR, GA, GB, GD, GE, GH, GM, GN, GQ, GR, GW, HR, HU, ID, IE, IL, IN, IS, IT, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MC, MD, MG, MK, ML, MN, MR, MW, MX, MZ, NA, NE, NG, NI, NL, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SI, SK, SL, SM, SN, SY, SZ, TD, TG, TJ, TM, TN, TR, TT, TZ, UA, UG, UZ, VC, VN, YU, ZA, ZM, ZW only).
TEVA PHARMACEUTICALS USA, INC. [US/US]; 1090 Horsham ROAD, P.o. Box 1090, North Wales, Pennsylvania 19454 (US) (BB only).
INI, Santiago [IL/IL]; (IL) (For US Only).
SHMUELI, Yaron [IL/IL]; (IL) (For US Only).
KOLTAI, Tamás [IL/IL]; (IL) (For US Only).
GOLD, Amir [IL/IL]; (IL) (For US Only)
Inventors: INI, Santiago; (IL).
SHMUELI, Yaron; (IL).
KOLTAI, Tamás; (IL).
GOLD, Amir; (IL)
Agent: BRAINARD, Charles, R.; KENYON & KENYON LLP, One Broadway, New York, New York 10004-1050 (US)
Priority Data:
60/647,888 27.01.2005 US
Title (EN) DULOXETINE HYDROCHLORIDE POLYMORPHS
(FR) POLYMORPHES D'HYDROCHLORURE DE DULOXETINE
Abstract: front page image
(EN)A crystalline form of duloxetine hydrochloride, pharmaceutical compositions of the crystalline form of duloxetine hydrochloride, and methods of preparing the crystalline form of duloxetine hydrochloride are provided.
(FR)L'invention concerne une forme cristalline d'hydrochlorure de duloxetine, des compositions pharmaceutiques de cette forme, et des procédés d'élaboration de ladite forme.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)